Clinical Trials Sponsored by Journey Medical Corporation

Total 753 results

Journey Medical Corporation

Completed

Study of Glycopyrronium in Axillary Hyperhydrosis

Hyperhidrosis

United States, Germany
Journey Medical Corporation

Completed

Study of Glycopyrronium in Subjects With Axillary Hyperhidrosis

Hyperhidrosis

United States
Journey Medical Corporation

Completed

A Dose-Ranging Study of the Effect of Glycopyrrolate in Subjects With Axillary Hyperhidrosis

Hyperhidrosis

United States
Journey Medical Corporation

Completed

Long-term Safety Study of Glycopyrronium in Subjects With Primary Axillary Hyperhidrosis

Hyperhidrosis

United States, Germany
Journey Medical Corporation

Completed

A Study of Glycopyrronium Cloth, 2.4% in Patients With Palmar Hyperhidrosis

Palmar Hyperhidrosis

United States
Journey Medical Corporation

Completed

Comparator Study of the Effect of Glycopyrrolate and Glycopyrronium in Subjects With Axillary Hyperhidrosis

Hyperhidrosis

United States, Canada
Journey Medical Corporation
Dr. Reddy's Laboratories Limited

Completed

A Randomized, Double-Blind Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea. (MVOR-1)

Papulopustular Rosacea

United States
Journey Medical Corporation
Dr. Reddy's Laboratories Limited

Completed

Impact of DFD-29 on Microbial Flora of Healthy, Adult Human Subjects When Administered Over 16 Weeks

Rosacea

United States
Journey Medical Corporation
Dr. Reddy's Laboratories Limited

Completed

A Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea (MVOR-2) (MVOR-2)

Papulopustular Rosacea

United States, Germany
Journey Medical Corporation
Dr. Reddy's Laboratories Limited

Completed

A Comparative Bioavailability Study of DFD-29 Capsules 40 mg Versus SOLODYN® Tablets 105 mg, Under Fasting & Fed Conditions in Healthy Adult Human Subjects

Pharmacokinetics

Canada
Hamad Medical Corporation

Not yet recruiting

Programmed Intermittent Epidural Bolus (PIEB) Techniques for Labour Analgesia (PIEB)

Analgesia | Labor Pain | Obstetric Pain

Qatar
Hamad Medical Corporation

Recruiting

Impact of Sodium-glucose Cotransporter 2 Inhibitors on Post-operative Atrial Fibrillation in Cardiothoracic Surgery

Atrial Fibrillation

Qatar
Hamad Medical Corporation

Recruiting

Effects of Early Oral Diet After Cardiac Surgery: an Open Label Randomized Controlled Trial

Adult Cardiac Surgery

Qatar
Hamad Medical Corporation

Recruiting

Effect of Self-care Skill Education on the Compassionate Satisfaction and Compassionate Fatigue Among Clinical Nurses Clinical Nurses at HMC

Compassion Fatigue | Self-care | Educational Intervention | Compassion Satisfaction

Qatar
Hamad Medical Corporation

Recruiting

Effect of Transformational Leadership Programme on Unit Charge Nurses Leadership Practices

Leadership

Qatar
Terumo Medical Corporation

Recruiting

Kaitoh Atherectomy FIH

Peripheral Arterial Disease

New Zealand
Elixir Medical Corporation

Recruiting

A Clinical Trial to Assess the Elixir Medical LithiX Coronary Hertzian Contact Intravascular Lithotripsy Catheter (PINNACLE-I)

Coronary Artery Disease

Belgium, Netherlands
Hamad Medical Corporation

Recruiting

Efficacy and Clinical Outcomes of Levosimendan in E-CPR (ECPR)

Cardiogenic Shock | Extracorporeal Membrane Oxygenation Complication

Qatar
Hamad Medical Corporation

Recruiting

Predictors of Mortality in Patients With VA-Extracorporeal Membrane Oxygenation. (ECMO)

Morality | VA-ECMO

Qatar
Hamad Medical Corporation

Not yet recruiting

Appropriateness of Carpal Tunnel Syndrome Management Compared With the AAOS Appropriate Use Criteria (CTS)

Carpal Tunnel Syndrome
Hamad Medical Corporation

Recruiting

Omega-3 Oil Use in COVID-19 Patients in Qatar (Omega3)

COVID-19

Qatar
Hamad Medical Corporation

Recruiting

Inflammatory Markers Dynamics in Response to Extra-corporeal Membrane Oxygenator Decannulation (ECMO)

Inflammatory Markers Changes in Response to Extra-corporeal Membrane Oxygenator Decannulation

Qatar
Hamad Medical Corporation

Recruiting

Efficacy of Corticosteroids in Reducing Renal Scarring in Acute Pyelonephritis in Children

Chronic Renal Failure | Urinary Tract Infections in Children | UTI | Dexamethasone | Acute Pyelonephritis | Kidney Scarring | Hypertension in Children

Qatar
Zoll Medical Corporation

Recruiting

Optimizing Beta Blocker Dosage in Women While Using the Wearable Cardioverter Defibrillator (OPT-BB WOMEN)

Heart Failure | Cardiomyopathies

United States
Zoll Medical Corporation

Recruiting

Accuracy of Cardiac Acoustic Biomarkers Recorded by the Wearable Cardioverter Defibrillator (ACAB)

Heart Failure

United States
Zoll Medical Corporation

Completed

Verification of Prediction Algorithm (VPAC)

Bradycardia | Tachycardia | Difficulty Breathing | Shortness of Breath Episode

United States, Belgium
Zoll Medical Corporation

Completed

Benefits of Microcor in Ambulatory Decompensated Heart Failure (BMAD-TX)

Heart Failure

United States, Germany, Austria, France
SetPoint Medical Corporation

Active, not recruiting

Vagus Nerve Stimulation for Moderate to Severe Rheumatoid Arthritis (RESET-RA)

Rheumatoid Arthritis

United States
Hamad Medical Corporation

Completed

Association Between COVID-19 and UTIs Caused by ESBL Organism in Infants (ABCUCEOI)

Renal Insufficiency

Qatar
Hamad Medical Corporation

Completed

COVID-19 Among Children With Chronic Renal Diseases in Qatar (CCCRDQ)

Chronic Kidney Diseases | Acute Kidney Injury | COVID-19 Pandemic | COVID-19 Infection | Chronic Renal Failure in Children

Qatar
Zoll Medical Corporation

Withdrawn

Mobile Advanced Multi-Parameter Reporting in Patients Wearing a Novel Device: Utilization During Cardiac Rehabilitation (MAPS-III)

Cardiac Event | Cardiac Disease | STEMI | Heart Attack | Cardiac Infarct | NSTEMI
Zoll Medical Corporation

Enrolling by invitation

Rapid Treatment of Shock Without Trauma (SWOT)

Shock

United States
Terumo Medical Corporation

Completed

Observational Study to Assess Transradial Access for Treatment in the Lower Extremities. (R2P Registry)

Peripheral Arterial Disease

United States
Zoll Medical Corporation

Completed

Mobile Cardiac Telemetry and Advanced Multi-Parameter Monitoring in PatientS Wearing a Novel Device With Biometric Based Medications Changes (MAPS II)

Cardiac Arrhythmia

United States
Zoll Medical Corporation

Enrolling by invitation

AED 3 Post-Approval Study

Cardiac Arrest, Out-Of-Hospital

United States
Hamad Medical Corporation

Completed

Synergistic Effect Of Parenteral Diclofenac And Paracetamol In The Pain Management Of Acute Limb Injuries

Musculoskeletal Injury

Qatar
Hamad Medical Corporation

Completed

Anakinra in the Management of COVID-19 Infection

Pneumonia | Covid19 | Corona Virus Infection | Cytokine Release Syndrome | Viral Infection

Qatar
Hamad Medical Corporation

Terminated

Evaluation of Hydrocortisone, Vitamin C and Thiamine for the Treatment of Septic Shock (HYVITS)

Critical Illness | Septic Shock

Qatar
Zoll Medical Corporation

Completed

Heart Sounds Measurement Using the Wearable Cardioverter Defibrillator (HS-WCD) Study

Heart Failure

United States
Hamad Medical Corporation

Unknown

18F-FLT (PET/CT) in Prefibrotic/Early Primary Myelofibrosis and Essential Thrombocythemia (PMF/ET-FLT)

Essential Thrombocythemia | Primary Myelofibrosis, Prefibrotic Stage | Primary Myelofibrosis, Fibrotic Stage

Qatar
Zoll Medical Corporation

Completed

LifeVest Trends Validation Protocol (TRENDS)

Heart Failure

United States, Germany, Austria
Hamad Medical Corporation

Unknown

Assessment of Mental Health in Healthcare Workers Exposed to COVID-19 Patients (BADS-PTSD)

COVID-19

Qatar
Hamad Medical Corporation

Unknown

Anticoagulation in Patients Suffering From COVID-19 Disease The ANTI-CO Trial

Anticoagulation in COVID-19 ARDS

Qatar
Hamad Medical Corporation

Terminated

Denosumab Versus Zoledronic Acid in Thalassemia-Induced Osteoporosis (DOHA)

Osteoporosis | Thalassemia Majors (Beta-Thalassemia Major)

Qatar
Zoll Medical Corporation

Completed

LifeVest Safety and Efficacy in Real Life Settings in France (WEARIT France)

Sudden Cardiac Death | Cardiac Event | Cardiac Arrythmias | Left Ventricular Dysfunction

France
Hamad Medical Corporation

Completed

Comparing Two-time Points of Thyroid Hormone Replacement During the Holy Month of Ramadan

Hypothyroidism

Qatar
Hamad Medical Corporation

Unknown

Effect of Dapagliflozin on the Progression From Prediabetes to T2DM in Subjects With Myocardial Infarction

Myocardial Infarction | PreDiabetes | CVD | T2DM (Type 2 Diabetes Mellitus)

Qatar
SetPoint Medical Corporation

Completed

Safety and Efficacy of Vagus Nerve Stimulator in Patients With Rheumatoid Arthritis (RA)

Rheumatoid Arthritis

United States
Zoll Medical Corporation

Completed

Study of the Wearable Defibrillator in Heart-Failure Patients (SWIFT)

Heart Failure | Ventricular Fibrillation | Ventricular Tachycardia | Ventricular Dysfunction | Sudden Death | Sudden Cardiac Arrest

Israel, United States
Hamad Medical Corporation

Completed

Comparison Among Erythropoietin Stimulating Agents

Anemia of End Stage Renal Disease

Qatar

Clinical Trials Sponsored by Journey Medical Corporation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Argentina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations